Global 510(k) approvals (2005-2025) and India's presence-A Market Analysis

Global 510(k) Approvals (2005–2025): Market Analysis

The FDA 510(k) approvals pathway remains a cornerstone for medical device market entry into the United States. Between 2005 and May 2025, approximately 63,100 FDA 510(k) approvals were granted globally, covering diagnostic devices, surgical instruments, implants, and AI-driven technologies. This data highlights strong global participation in the FDA 510(k) approvals system and reflects increasing regulatory maturity across markets.

Global Snapshot

Total FDA 510(k) approvals (2005–2025): 63,100
United States: 68.0% of total FDA 510(k) approvals
China: 7.7%
Germany & South Korea: 2.9% each
Taiwan: 2.0%
India: 0.34

India’s Presence in FDA 510(k) Approvals

India secured 215 FDA 510(k) approvals, contributing 0.34% to global FDA 510(k) approvals. While relatively modest, India’s participation in FDA 510(k) approvals has grown steadily, particularly after 2018, peaking between 2022 and 2024.

Key Insights

India’s total FDA 510(k) approvals: 215
Top 10 Indian companies: Account for ~39% of India’s FDA 510(k) approvals
Growth driven by AI innovation, improved GMP compliance, and export-focused MedTech strategies

Although India’s share of FDA 510(k) approvals remains small, the upward trend signals expanding regulatory capability and stronger positioning in the global medical device market.